nifedipine CR tablets (Xin Ran)
Sponsors
Shanghai Shyndec Pharmaceutical Co., Ltd.
Conditions
Essential Hypertension
Phase 4
Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension
CompletedNCT02031861
Start: 2014-02-28End: 2014-07-31Updated: 2015-02-05
Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure
NCT02357615
Start: 2014-12-31End: 2015-09-30Target: 244Updated: 2015-02-06